Latest Headlines
- What the Evidence Says for Guided Imagery in Oncologic Care
- FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory, Systemic ALK-Positive Anaplastic Large Cell Lymphoma
- Nurses Break Record as Most Trusted Profession for 19 Years Running
- How to Accept Criticism With Class
COVID-19 and Cancer
- Biden Appoints Nurse to COVID-19 Advisory Board January 06, 2021
- CDC Offers Infection Prevention Guidelines for Patients With Cancer During COVID-19 January 06, 2021
- Superhero Nurses Shine in Marvel Comic Book January 05, 2021
- NIH Announces COVID-19 Initiative to Connect With High-Risk Patient Populations December 15, 2020
- COVID-19 Reference Sheet: Vaccines December 14, 2020
Our Spirit. Our Practice.

Sharon is a 60-year-old woman with metastatic breast cancer that was originally diagnosed in 2005 and treated with a mastectomy, deep inferior epigastric artery perforator flap reconstruction, chemotherapy, post mastectomy radiation, and five years of tamoxifen. Three months ago, her breast cancer recurred, and staging scans demonstrated metastatic disease in the lungs, left axilla, liver, and left iliac bone. A biopsy of the left iliac bone was ER positive, PR negative, and HER2 negative. Sharon began treatment with radiation to the painful left hip and letrozole, with the plan to start palbociclib once radiation was completed.